Title:
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2024/101336
Kind Code:
A1
Abstract:
One embodiment of the present invention provides a compound, or a pharmaceutically acceptable salt thereof, capable of suppressing the splicing anomalies that are a factor in the onset or progression of disease. This disclosure relates to, according to one embodiment, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
Inventors:
HAGIWARA MASATOSHI
AWAYA TOMONARI
AJIRO MASAHIKO
GOTANDA KENTOKU
TAKEMOTO NAOHIRO
NOJI TOSHIHARU
AWAYA TOMONARI
AJIRO MASAHIKO
GOTANDA KENTOKU
TAKEMOTO NAOHIRO
NOJI TOSHIHARU
Application Number:
PCT/JP2023/039979
Publication Date:
May 16, 2024
Filing Date:
November 07, 2023
Export Citation:
Assignee:
UNIV KYOTO (JP)
International Classes:
C07D239/95; A61K31/517; A61K31/519; A61P3/00; A61P43/00; C07D401/12; C07D405/12; C07D405/14; C07D409/12; C07D413/12; C07D413/14; C07D417/12; C07D471/04
Attorney, Agent or Firm:
IKEUCHI & PARTNERS (JP)
Download PDF: